Related Experiment Video
Updated: Aug 20, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Developments in HIV treatments: strategies for success
1Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut, USA.
Abstract:
The current primary goal of therapy for HIV-1 infection is suppression of viral replication to below detectable levels (less than 50 copies/mL). The most important challenge facing current HIV-1 research is designing agents that prevent the emergence of or overcome drug-resistant HIV-1 variants. Shortcomings of antiretroviral therapy have sparked interest in immunologic enhancement through vaccines and immunomodulators, specifically antigen stimulation, induction of HIV-1 specific memory and cytotoxic T-cell responses, and activation of resting CD4+ cells within latent HIV-1 reservoirs. New classes of antiretroviral agents include entry inhibitors and nucleotide reverse transcriptase inhibitors. This article discusses the status of successful HIV treatment strategies, including new treatment practices, antiretroviral agents, and immune-enhancing agents.
Related Concept Videos
Retrovirus Life Cycles
Inhibitors of Virion Maturation and Assembly
Sexually Transmitted Infections
Inhibitors of Viral Protein Synthesis
Antiviral Nucleoside Inhibitors
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

